Blossomhill Therapeutics, Inc. · NASDAQ:BLSM

Cui Jingrong Jean converted 1,838,896 Blossomhill Therapeutics, Inc. shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 10, 2026

On Aug 10, 2026, Cui Jingrong Jean (Director, President and CEO, 10% owner) converted 1,838,896 Blossomhill Therapeutics, Inc. shares, leaving 124,779 shares. Filed Aug 10, 2026 (Form 4).

Converted
1,838,896 shares
Holding after
124,779 shares (held indirectly)
Trading plan
No
Role
Director, President and CEO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockConversion1,600,6821,600,682Indirect
Aug 10, 2026Common StockConversion113,4351,714,117Indirect
Aug 10, 2026Common StockConversion124,779124,779Indirect

Source

View original at SEC

Related